Leading to a new generation of therapies with HEK 293 cells and Adenovirus vectors
TM
AdVec Inc. was founded in 1996 to distribute and license HEK293 cells and adenovirus vector technologies and reagents developed by Dr. Frank Graham and his team at McMaster University, Canada.
